Sustaining Cardiac Claudin-5 Levels Prevents Functional Hallmarks of Cardiomyopathy in a Muscular Dystrophy Mouse ModelMOLECULAR THERAPYIF122012-07-0122OAAI
Response to Letter Regarding Article, Early Treatment With Lisinopril and Spironolactone Preserves Cardiac and Skeletal Muscle in Duchenne Muscular Dystrophy MiceCIRCULATIONIF38.62012-03-060OAAI
Early Treatment With Lisinopril and Spironolactone Preserves Cardiac and Skeletal Muscle in Duchenne Muscular Dystrophy MiceCIRCULATIONIF38.62011-08-02123OAAI
Claudin-5 levels are reduced in human end-stage cardiomyopalhyJOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGYIF4.72008-07-0132PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向